Referenzen

Adam, E., Kerkhofs, P., Mammerickx, M., Burny, A., Kettman, R., Willems, L., The CREB, ATF-1, and ATF-2 transcription factors from bovine leukemia virus-infected B lymphocytes activate viral expression., J Virol., 1996, (70), 1990-1999.

Adam, P.J., Boyd, R., Tyson, K.L., Fletcher, G.C., Stamps, A., Hudson, L., Poyser, H.R., Redpath, N., Griffiths, M., Steers, G., Harris, A.L., Patel, S., Berry, J., Loader, J.A., Townsend, R.R., Daviet, L., Legrain, P., Parekh, R., Terrett, J.A., Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer., J Biol. Chem., 2003, (278), 6482-6489.

Adams, A.T. und Auersperg, N., A cell line, ROSE 199, derived from normal rat ovarian surface epithelium., Exp. Cell Biol., 1985, (53), 181-188.

Akiyama, H., Hiraki, Y., Noda, M., Shigeno, C., Ito, H., Nakamura, T., Molecular cloning and biological activity of a novel Ha-Ras suppressor gene predominantly expressed in skeletal muscle, heart, brain, and bone marrow by differential display using clonal mouse EC cells, ATDC5., J. Biol. Chem., 1999, (274), 32192-32197.

Alsayed, Y., Uddin, S., Ahmad, S., Majchrzak, B., Druker, B.J., Fish, E.N., Platanias, L.C., IFN-gamma activates the C3G/Rap1 signaling pathway ., J Immunol., 2000, (164), 1800-1806.

Anantharaman, V. und Aravind, L., Evolutionary history, structural features and biochemical diversity of the NlpC/P60 superfamily of enzymes., Genome Biol., 2003, (4).

Baeuerle, P.A. und Baltimore, D ., NF-kappa B: ten years after., Cell., 1996, (87), 13-20.

Baker, K.M., Wei, G., Schaffner, A.E., Ostrowski, M.C., Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCA1 promoter., J Biol. Chem., 2003, (278), 17876-17884.

Barber, G.N.,The interferons and cell death: guardians of the cell or accomplices of apoptosis?, Semin. Cancer Biol., 2000, (10), 103-111.

Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S., Baltimore, D.,Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B., Nature., 1995, (376), 167-170.

Bluyssen, H.A. und Levy, D.E., Stat2 is a transcriptional activator that requires sequence-specific contacts provided by stat1 and p48 for stable interaction with DNA ., J Biol. Chem., 1997, (272), 4600-4605.

Bokar, J.A., Roesler, W.J., Vandenbark, G.R., Kaetzel, D.M., Hanson, R.W., Nilson, J.H ., Characterization of the cAMP responsive elements from the genes for the alpha-subunit of glycoprotein hormones and phosphoenolpyruvate carboxykinase (GTP). Conserved features of nuclear protein binding between tissues and species ., J Biol. Chem., 1988, (263), 19740-19747.

Bonello, M.R. und Khachigian, L.M.,Fibroblast growth factor-2 represses platelet-derived growth factor receptor-alpha (PDGFR-alpha) transcription via ERK1/2-dependent Sp1 phosphorylation and an atypical cis-acting element in the proximal PDGFR-alpha promoter ., J Biol. Chem., 2004, (279), 2377-2382.

Bottrel, R.L.A., Yang, Y., Levy, D.L., Tomai, M., Reis, L.F.L., The Immune Response Modifier Imiquimod Requires STAT-1 for induction of Interferon, Interferon-Stimulated Genes, and Interleukin 6., Antimicrob. Agents Chemother., 1999, (43), 856-861

Bos, J.L.,ras oncogenes in human cancer: a review ., Cancer Res., 1989, (49), 4682-4689.

Burke, T.W. und Kadonaga, J.T., The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila., Genes Dev., 1997, (11), 3020-3031.

Butler, J.E. und Kadonaga, J.T., The RNA polymerase II core promoter: a key component in the regulation of gene expression., Genes Dev., 2002, (16), 2583-2592.

Chalkley, G.E. und Verrijzer, C.P., DNA binding site selection by RNA polymerase II TAFs: a TAF(II)250-TAF(II)150 complex recognizes the initiator., EMBO J., 1999, (18), 4835-4845.

Chen, B., He, L., Savell, V.H., Jenkins, J.J., Parham, D.M., Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region., Cancer Res., 2000, (60), 3290-3298.

Coccia, E.M., Del Russo, N., Stellacci, E., Orsatti, R., Benedetti, E., Marziali, G., Hiscott, J., Battistini, A.,Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2., Oncogene., 1999, (18), 2129-2137.

Conaway, J.W. und Conaway, R.C., Initiation of eukaryotic messenger RNA synthesis., J Biol. Chem., 1991, (266), 17721-17724.

Dale, T.C., Rosen, J.M., Guille, M.J., Lewin, A.R., Porter, A.G., Kerr, I.M., Stark, G.R., Overlapping sites for constitutive and induced DNA binding factors involved in interferon-stimulated transcription., EMBO J., 1989, (8), 831-839.

de Martin, R., Schmid, J.A., Hofer-Warbinek, R., The NF-kappaB/Rel family of transcription factors in oncogenic transformation and apoptosis., Mutat. Res., 1999, (437), 231-243.

De Saint, J.M., Debbasch, C., Rahmani, M., Brignole, F., Feldmann, G., Warnet, J.M., Baudouin, C.,Fas- and interferon gamma-induced apoptosis in Chang conjunctival cells: further investigations., Invest Ophthalmol. Vis. Sci., 2000, (41), 2531-2543.

Della Fazia, M.A., Servillo, G., Sassone-Corsi, P.,Cyclic AMP signalling and cellular proliferation: regulation of CREB and CREM., FEBS Lett., 1997, (410), 22-24.

Der, S.D., Zhou, A., Williams, B.R., Silverman, R.H.,Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays., Proc. Natl. Acad. Sci. U. S. A., 1998, (95), 15623-15628.

Di Croce, L., Raker, V.A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo, C.F., Kouzarides, T., Nervi, C., Minucci, S., Pelicci, P.G., Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor., Science., 2002, (295), 1079-1082.

DiSepio, D., Ghosn, C., Eckert, R.L., Deucher, A., Robinson, N., Duvic, M., Chandraratna, R.A., Nagpal, S., Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene ., Proc. Natl. Acad. Sci. U. S. A., 1998, (95), 14811-14815.

Drew, P.D., Franzoso, G., Becker, K.G., Bours, V., Carlson, L.M., Siebenlist, U., Ozato, K.,NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression., J Interferon Cytokine Res., 1995, (15), 1037-1045.

Du, W. und Maniatis, T., An ATF/CREB binding site is required for virus induction of the human interferon beta gene [corrected]., Proc. Natl. Acad. Sci. U. S. A., 1992, (89), 2150-2154.

El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., Vogelstein, B., WAF1, a potential mediator of p53 tumor suppression., Cell., 1993, (75), 817-825.

Esteller, M., Cordon-Cardo, C., Corn, P.G., Meltzer, S.J., Pohar, K.S., Watkins, D.N., Capella, G., Peinado, M.A., Matias-Guiu, X., Prat, J., Baylin, S.B., Herman, J.G., p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2., Cancer Res., 2001, (61), 2816-2821.

Esteller, M., Fraga, M.F., Paz, M.F., Campo, E., Colomer, D., Novo, F.J., Calasanz, M.J., Galm, O., Guo, M., Benitez, J., Herman, J.G., Cancer epigenetics and methylation., Science., 2002, (297), 1807-1808.

Evans, R., Fairley, J.A., Roberts, S.G., Activator-mediated disruption of sequence-specific DNA contacts by the general transcription factor TFIIB., Genes Dev., 2001, (15), 2945-2949.

Falvo, J.V., Parekh, B.S., Lin, C.H., Fraenkel, E., Maniatis, T., Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation., Mol. Cell Biol., 2000, (20), 4814-4825.

Franek, W.R., Horowitz, S., Stansberry, L., Kazzaz, J.A., Koo, H.C., Li, Y., Arita, Y., Davis, J.M., Mantell, A.S., Scott, W., Mantell, L.L., Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells., J Biol. Chem., 2001, (276), 569-575.

Fukushima, A., Okuda, A., Nishimoto, M., Seki, N., Hori, T.A., Muramatsu, M., Characterization of functional domains of an embryonic stem cell coactivator UTF1 which are conserved and essential for potentiation of ATF-2 activity., J Biol. Chem., 1998, (273), 25840-25849.

Gabriel, H.D., Strobl, B., Hellmann, P., Buettner, R., Winterhager, E., Organization and regulation of the rat Cx31 gene. Implication for a crucial role of the intron region., Eur. J Biochem., 2001, (268), 1749-1759.

Gatto, L., Berlato, C., Poli, V., Tininini, S., Kinjyo, I., Yoshimura, A., Cassatella, M.A., Bazzoni, F., Analysis of SOCS-3 promoter responses to interferon gamma., J Biol. Chem., 2004, (279), 13746-13754.

Giroux, M., Schmidt, M., Descoteaux, A., IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha., J Immunol., 2003, (171), 4187-4194.

Hai, T. und Curran, T., Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity., Proc. Natl. Acad. Sci. U. S. A., 1991, (88), 3720-3724.

Hai, T.W., Liu, F., Coukos, W.J., Green, M.R., Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers., Genes Dev., 1989, (3), 2083-2090.

Hajnal, A., Klemenz, R., Schafer, R., Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts., Cancer Res., 1993, (53), 4670-4675.

Hanahan, D. und Weinberg, R.A., The hallmarks of cancer., Cell., 2000, (100), 57-70.

Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., Taniguchi, T., Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes., Cell., 1989, (58), 729-739.

Harada, H., Kitagawa, M., Tanaka, N., Yamamoto, H., Harada, K., Ishihara, M., Taniguchi, T., Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2., Science., 1993, (259), 971-974.

Harada, H., Kondo, T., Ogawa, S., Tamura, T., Kitagawa, M., Tanaka, N., Lamphier, M.S., Hirai, H., Taniguchi, T., Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; A possible mechanism of tumor suppressor inactivation., Oncogene., 1994, (9), 3313-3320.

Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.P., Davidson, N.E., Sidransky, D., Baylin, S.B., Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers., Cancer Res., 1995, (55), 4525-4530.

Hughes, P.J. und Stanway, G., The 2A proteins of three diverse picornaviruses are related to each other and to the H-rev107 family of proteins involved in the control of cell proliferation., J. Gen. Virol., 2000, (81), 201-207.

Husmann, K., Sers, C., Fietze, E., Mincheva, A., Lichter, P., Schäfer, R., Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12., Oncogene., 1998, (17), 1305-1312.

Ihle, J.N. und Kerr, I.M., Jaks and Stats in signaling by the cytokine receptor superfamily., Trends Genet., 1995, (11), 69-74.

Ince, T.A. und Scotto, K.W., A conserved downstream element defines a new class of RNA polymerase II promoters., J Biol. Chem., 1995, (270), 30249-30252.

Issa, JP., Garcia-Manero, G., Giles, F., Mannari, R., Thomas, D., Faderl, S., Bayar, E., Lyons, J., Rosenfeld, C., Cortes, J., Kantarjian, H., Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2´-deoxycytidine (decitabine) in hematopoietic malignancies., Blood., 2004, (103), 1635-1640.

Ito, H., Akiyama, H., Shigeno, C., Nakamura, T., Isolation, characterization, and chromosome mapping of a human A-C1 Ha-Ras suppressor gene (HRASLS)., Cytogenet Cell Genet., 2001, (93), 36-39.

Joyce, G.F., Directed molecular evolution., Sci. Am., 1992, (267), 90-97.

Jung, D., Jaeger, E., Cayeux, S., Blankenstein, T., Hilmes, C., Karbach, J., Moebius, U., Knuth, A., Huber, C., Seliger, B., Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes., Hum. Gene Ther., 1998, (9), 53-62.

Kaplan, D.H., Shankaran, V., Dighe, A.S., Stockert, E., Aguet, M., Old, L.J., Schreiber, R.D., Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice., Proc. Natl. Acad. Sci. U. S. A., 1998, (95), 7556-7561.

Kirchhoff, S. und Hauser, H., Cooperative activity between HER oncogenes and the tumor suppressor IRF- 1 results in apoptosis., Oncogene., 1999, (18), 3725-3736.

Klampfer, L., Huang, J., Corner, G., Mariadason, J., Arango, D., Sasazuki, T., Shirasawa, S., Augenlicht, L., Oncogenic k-ras inhibits the expression of IFN-responsive genes through inhibition of STAT1 and STAT2 expression., J. Biol. Chem., 2003.

Kontgen, F., Grumont, R.J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., Gerondakis, S., Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression., Genes Dev., 1995, (9), 1965-1977.

Kroger, A., Dallugge, A., Kirchhoff, S., Hauser, H., IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo., Oncogene., 2003, (22), 1045-1056.

Kuchinke, W., Hart, R.P., Jonakait, G.M., Identification of mRNAs regulated by interferon-gamma in cultured rat astrocytes by PCR differential display., Neuroimmunomodulation., 1995, (2), 347-355.

Kuivaniemi, H., Partial characterization of lysyl oxidase from several human tissues., Biochem. J., 1985, (230), 639-643.

Kumar, A., Yang, Y.L., Flati, V., Der, S., Kadereit, S., Deb, A., Haque, J., Reis, L., Weissmann, C., Williams, B.R., Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB., EMBO J., 1997, (16), 406-416.

Kurzrock, R., Gutterman, J.U., Talpaz, M., The molecular genetics of Philadelphia chromosome-positive leukemias., N. Engl. J Med., 1988, (319), 990-998.

Kutach, A.K. und Kadonaga, J.T., The downstream promoter element DPE appears to be as widely used as the TATA box in Drosophila core promoters., Mol. Cell Biol., 2000, (20), 4754-4764.

Lagrange, T., Kapanidis, A.N., Tang, H., Reinberg, D., Ebright, R.H., New core promoter element in RNA polymerase II-dependent transcription: sequence-specific DNA binding by transcription factor IIB., Genes Dev., 1998, (12), 34-44.

Lalli, E. und Sassone-Corsi, P., Signal transduction and gene regulation: the nuclear response to cAMP., J Biol. Chem., 1994, (269), 17359-17362.

Larsen, N.I., Engelbrecht, J., Brunak, S., Analysis of eukaryotic promoter sequences reveals a systematically occurring CT-signal., Nucleic Acids Res., 1995, (23), 1223-1230.

Li, E., Beard, C., Jaenisch, R., Role for DNA methylation in genomic imprinting., Nature., 1993, (366), 362-365.

Li, X.Y. und Green, M.R., Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain., Genes Dev., 1996, (10), 517-527.

Liu, J., Shue, E., Ewalt, K.L., Schimmel, P., A new gamma-interferon-inducible promoter and splice variants of an anti-angiogenic human tRNA synthetase., Nucleic Acids Res., 2004, (32), 719-727.

Lotz, K. und Sers, C., Manuskript eingereicht

Malik, S.T., Knowles, R.G., East, N., Lando, D., Stamp, G., Balkwill, F.R., Antitumor activity of gamma-interferon in ascitic and solid tumor models of human ovarian cancer., Cancer Res., 1991, (51), 6643-6649.

Mashimo, T., Watabe, M., Hirota, S., Hosobe, S., Miura, K., Tegtmeyer, P.J., Rinker-Shaeffer, C.W., Watabe, K.,The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53., Proc. Natl. Acad. Sci. U. S. A., 1998, (95), 11307-11311.

Mecucci, C., Ghione, F., Tricot, G., van den, B.H.,Combined trisomy 1q and monosomy 7q due to translocation 1;7 in myelodysplastic syndromes., Cancer Genet. Cytogenet., 1985, (18), 193-197.

Mori, K., Stone, S., Khaodhiar, L., Braverman, L.E., DeVito, W.J., Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells ., J Cell Biochem., 1999, (74), 211-219.

Muller, F.U., Neumann, J., Schmitz, W.,Transcriptional regulation by cAMP in the heart., Mol. Cell Biochem., 2000, (212), 11-17.

Nazarenko I., Sers C., submitted, 2004

Ng, M.H., Chung, Y.F., Lo, K.W., Wickham, N.W., Lee, J.C., Huang, D.P., Frequent hypermethylation of p16 and p15 genes in multiple myeloma., Blood., 1997, (89), 2500-2506.

Nguyen, H., Ramana, C.V., Bayes, J., Stark, G.R., Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression., J Biol. Chem., 2001, (276), 33361-33368.

Norris, J.L. und Baldwin, A.S., Jr., Oncogenic Ras enhances NF-kappaB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways ., J Biol. Chem., 1999, (274), 13841-13846.

Nozawa, H., Oda, E., Ueda, S., Tamura, G., Maesawa, C., Muto, T., Taniguchi, T., Tanaka, N., Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer., Int. J. Cancer., 1998, (77), 522-527.

Oberhuber, H., Seliger, B., Schafer, R ., Partial restoration of pre-transformation levels of lysyl oxidase and transin mRNAs in phenotypic ras revertants., Mol. Carcinog., 1995, (12), 198-204.

Ohmori, Y., Schreiber, R.D., Hamilton, T.A.,Synergy between Interferon-g and Tumor Necrosis Factor-a in Transcriptional Activation Is Mediated by Cooperation between Signal Transducer and Activator of Transcription 1 and Nuclear Factor kB, J. Biol. Chem., (272), 14899-14907

Pine, R., Decker, T., Kessler, D.S., Levy, D.E., Darnell, J.E., Jr., Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either., Mol. Cell Biol., 1990, (10), 2448-2457.

Pine, R., Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element., Nucleic Acids Res., 1997, (25), 4346-4354.

Piskurich, J.F., Wang, Y., Linhoff, M.W., White, L.C., Ting, J.P., Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene., J Immunol., 1998, (160), 233-240.

Prives, C., Signaling to p53: breaking the MDM2-p53 circuit., Cell., 1998, (95), 5-8.

Ramana, C.V., Gil, M.P., Schreiber, R.D., Stark, G.,R., Stat1-dependent and –independent pathways in IFN- γ -dependent signaling., Trends in Immunology, 2002, (23), 96-101.

Rando, R.R., Membrane-bound lecithin-retinol acyltransferase., Biochem. Biophys. Res. Commun., 2002, (292), 1243-1250.

Reik, W. und Walter, J., Genomic imprinting: parental influence on the genome., Nat Rev Genet., 2001, (2), 21-32.

Robinson, C.M., Shirey, K.A., Carlin, J.M., Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha ., J Interferon Cytokine Res., 2003, (23), 413-421.

Roder, K., Latasa, M.J., Sul, H.S., Murine H-rev107 gene encoding a class II tumor suppressor: gene organization and identification of an Sp1/Sp3-binding GC-box required for its transcription., Biochem. Biophys. Res. Commun., 2002, (293), 793-799.

Roesler, W.J., Vandenbark, G.R., Hanson, R.W., Cyclic AMP and the induction of eukaryotic gene transcription., J Biol. Chem., 1988, (263), 9063-9066.

Rudge, T.L. und Johnson, L.F., Inactivation of MED-1 elements in the TATA-less, initiator-less mouse thymidylate synthase promoter has no effect on promoter strength or the complex pattern of transcriptional start sites., J Cell Biochem., 1999, (73), 90-96.

Saito, T., Berens, M.E., Welander, C.E., Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assay., Cancer Res., 1986, (46), 1142-1147.

Sanchez-Cespedes, M., Parrella, P., Esteller, M., Nomoto, S., Trink, B., Engles, J.M., Westra, W.H., Herman, J.G., Sidransky, D., Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung., Cancer Res., 2002, (62), 3659-3662.

Sen, R. und Baltimore, D., Multiple nuclear factors interact with the immunoglobulin enhancer sequences., Cell., 1986, (46), 705-716.

Sers, C., Emenegger, U., Husmann, K., Bucher, K., Andres, A.-C., Schäfer, R., Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors ., J. Cell. Biol., 1997, (136), 935-944.

Shayesteh, L., Lu, Y., Kuo, W.L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G.B., Gray, J.W., PIK3CA is implicated as an oncogene in ovarian cancer., Nat Genet., 1999, (21), 99-102.

Sherr, C.J. und Roberts, J.M., CDK inhibitors: positive and negative regulators of G1-phase progression., Genes Dev., 1999, (13), 1501-1512.

Singer, V.L., Wobbe, C.R., Struhl, K., A wide variety of DNA sequences can functionally replace a yeast TATA element for transcriptional activation., Genes Dev., 1990, (4), 636-645.

Smale, S.T.,Core promoters: active contributors to combinatorial gene regulation., Genes Dev., 2001, (15), 2503-2508.

Stevaux, O. und Dyson, N.J., A revised picture of the E2F transcriptional network and RB function., Curr. Opin. Cell Biol., 2002, (14), 684-691.

Strausberg, R.L., Feingold, E.A., Grouse, L.H., Derge, J.G., Klausner, R.D., Collins, F.S., Wagner, L., Shenmen, C.M., Schuler, G.D., Altschul, S.F., Zeeberg, B., Buetow, K.H., Schaefer, C.F., Bhat, N.K., Hopkins, R.F., Jordan, H., Moore, T., Max, S.I., Wang, J., Hsieh, F., Diatchenko, L., Marusina, K., Farmer, A.A., Rubin, G.M., Hong, L., Stapleton, M., Soares, M.B., Bonaldo, M.F., Casavant, T.L., Scheetz, T.E., Brownstein, M.J., Usdin, T.B., Toshiyuki, S., Carninci, P., Prange, C., Raha, S.S., Loquellano, N.A., Peters, G.J., Abramson, R.D., Mullahy, S.J., Bosak, S.A., McEwan, P.J., McKernan, K.J., Malek, J.A., Gunaratne, P.H., Richards, S., Worley, K.C., Hale, S., Garcia, A.M., Gay, L.J., Hulyk, S.W., Villalon, D.K., Muzny, D.M., Sodergren, E.J., Lu, X., Gibbs, R.A., Fahey, J., Helton, E., Ketteman, M., Madan, A., Rodrigues, S., Sanchez, A., Whiting, M., Madan, A., Young, A.C., Shevchenko, Y., Bouffard, G.G., Blakesley, R.W., Touchman, J.W., Green, E.D., Dickson, M.C., Rodriguez, A.C., Grimwood, J., Schmutz, J., Myers, R.M., Butterfield, Y.S., Krzywinski, M.I., Skalska, U., Smailus, D.E., Schnerch, A., Schein, J.E., Jones, S.J., Marra, M.A., Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences., Proc. Natl. Acad. Sci. U. S. A., 2002, (99), 16899-16903.

Sun, Y., Deng, D., You, W.C., Bai, H., Zhang, L., Zhou, J., Shen, L., Ma, J.L., Xie, Y.Q., Li, J.Y., Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study., Clin. Cancer Res., 2004, (10), 5087-5093.

Suzuki, Y., Yamashita, R., Nakai, K., Sugano, S., DBTSS: DataBase of human Transcriptional Start Sites and full-length cDNAs., Nucleic Acids Res., 2002, (30), 328-331.

Suzuki, Y. und Sugano, S., Construction of a full-length enriched and a 5'-end enriched cDNA library using the oligo-capping method., Methods Mol. Biol., 2003, (221), 73-91.

Szyf, M., DNA methylation and cancer therapy., Drug Resist. Updat., 2003, (6), 341-353.

Takahira, T., Oda, Y., Tamiya, S., Yamamoto, H., Kawaguchi, K., Kobayashi, C., Iwamoto, Y., Tsuneyoshi, M., Alterations of the p16INK4a/p14ARF pathway in clear cell sarcoma., Cancer Sci., 2004, (95), 651-655.

Takaoka, A., Tanaka, N., Mitani, Y., Miyazaki, T., Fujii, H., Sato, M., Kovarik, P., Decker, T., Schlessinger, J., Taniguchi, T., Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling., EMBO J., 1999, (18), 2480-2488.

Takaoka, A.S., Yamada, T., Gotoh, M., Kanai, Y., Imai, K., Hirohashi, S., Cloning and characterization of the human beta4-integrin gene promoter and enhancers ., J Biol. Chem., 1998, (273), 33848-33855.

Tamura, G., Ogasawara, S., Nishizuka, S., Sakata, K., Maesawa, C., Suzuki, Y., Terashima, M., Saito, K., Satodate, R., Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach., Cancer Res., 1996, (56), 612-615.

Tanaka, H. und Samuel, C.E., Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase., Proc. Natl. Acad. Sci. U. S. A., 1994, (91), 7995-7999.

Tanaka, N., Ishihara, M., Taniguchi, T., Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1., Cancer Lett., 1994, (83), 191-196.

Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M.S., Aizawa, S., Mak, T.W., Taniguchi, T., Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1., Cell., 1994, (77), 829-839.

Tanaka, N., Ishihara, M., Lamphier, M.S., Nozawa, H., Matsuyama, T., Mak, T.W., Aizawa, S., Tokino, T., Oren, M., Taniguchi, T., Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage., Nature., 1996, (382), 816-818.

Tanaka, N. und Taniguchi, T., The interferon regulatory factors and oncogenesis., Semin. Cancer Biol., 2004, (10), 73-81.

Tate, P.H. und Bird, A.P., Effects of DNA methylation on DNA-binding proteins and gene expression., Curr. Opin. Genet. Dev., 1993, (3), 226-231.

Tchernitsa, O.I., Sers, C., Zuber, J., Hinzmann, B., Grips, M., Schwendel, A., Rosenthal, A., Schäfer, R., The transcriptional basis of KRAS-oncogene-mediated transformation in ovarian epithelial cells., Oncogene., 2004, (in press),

Tiainen, M., Ylikorkala, A., Makela, T.P., Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest., Proc. Natl. Acad. Sci. U. S. A., 1999, (96), 9248-9251.

Todaro, G. und Green, H., Quantitative studies of the growth of mouse embryo cells in culture and their development into established cell lines., J. Cell Biol., 1963, (17), 299-313.

Trink, B., Pai, S.I., Spunt, S.L., Raman, V., Cairns, P., Jen, J., Gabrielson, E., Sukumar, S., Sidransky, D., Absence of TSG101 transcript abnormalities in human cancers., Oncogene., 1998, (16), 2815-2818.

Tsao, S.-W., Mok, S.C., Fey, E.G., Fletcher, J.A., Wan, T.S.K., Chew, E.-C., Muto, M.G., Knapp, R.C., Berkowitz, R.S., Characterization of human ovarian epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs)., Exp. Cell Res., 1995, (218), 499-507.

Tuveson, D.A. und Jacks, T ., Modeling human lung cancer in mice: similarities and shortcomings., Oncogene., 1999, (18), 5318-5324.

Uddin, S., Sher, D.A., Alsayed, Y., Pons, S., Colamonici, O.R., Fish, E.N., White, M.F., Platanias, L.C., Interaction of p59fyn with interferon-activated Jak kinases., Biochem. Biophys. Res. Commun., 1997, (235), 83-88.

Vlahos, C.J., Matter, W.F., Hui, K.Y., Brown, R.F., A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)., J. Biol. Chem., 1994, (269), 5241-5248.

von Lintig, F.C., Dreilinger, A.D., Varki, N.M., Wallace, A.M., Casteel, D.E., Boss, G.R., Ras activation in human breast cancer., Breast Cancer Res. Treat., 2000, (62), 51-62.

Wang, T., Lafuse, W.P., Zwilling, B.S., NFkappaB and Sp1 elements are necessary for maximal transcription of toll-like receptor 2 induced by Mycobacterium avium., J Immunol., 2001, (167), 6924-6932.

Ward, A.C., Hermans, M.H., Smith, L., van Aesch, Y.M., Schelen, A.M., Antonissen, C., Touw, I.P., Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration., Blood., 1999, (93), 113-124.

Waters, S.B., Holt, K.H., Ross, S.E., Syu, L.-J., Guan, K.-L., Saltiel, A.R., Koretzky, G.A., Pessin, J.E., Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex., J. Biol. Chem., 1995, (270), 20883-20886.

Watnick, R.S., Cheng, Y.N., Rangarajan, A., Ince, T.A., Weinberg, R.A., Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis., Cancer Cell., 2003, (3), 219-231.

Weih, F., Carrasco, D., Durham, S.K., Barton, D.S., Rizzo, C.A., Ryseck, R.P., Lira, S.A., Bravo, R., Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family., Cell., 1995, (80), 331-340.

Weinberg, R.A., The retinoblastoma protein and cell cycle control., Cell., 1995, (81), 323-330.

Willman, C.L., Sever, C.E., Pallavicini, M.G., Harada, H., Tanaka, N., Slovak, M.L., Yamamoto, H., Harada, K., Meeker, T.C., List, A.F., Taniguchi, T., Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preneoplastic myelodysplasia., Science., 1993, (259), 968-970.

Windbichler, G.H., Hausmaninger, H., Stummvoll, W., Graf, A.H., Kainz, C., Lahodny, J., Denison, U., Muller-Holzner, E., Marth, C., Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial., Br. J Cancer., 2000, (82), 1138-1144.

Xu, X., Kang, S.H., Heidenreich, O., Brown, D.A., Nerenberg, M.I., Sequence requirements of ATF2 and CREB binding to the human T-cell leukemia virus type 1 LTR R region., Virology., 1996, (218), 362-371.

Yang, B., Guo, M., Herman, J.G., Clark, D.P., Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma., Am. J Pathol., 2003, (163), 1101-1107.

Zeuthen, J., Norgaard, J.O., Avner, P., Fellous, M., Wartiovaara, J., Vaheri, A., Rosen, A., Giovanella, B.C., Characterization of a human ovarian teratocarcinoma-derived cell line., Int J Cancer., 1980, (25), 19-32.

Zhang, B., Liu, S., Perpetua, M.D., Walker, W.H., Harbrecht, B.G., Cytokines increase CRE binding but decrease CRE-mediated reporter activity in rat hepatocytes by increasing c-Jun., Hepatology., 2004, (39), 1343-1352.

Zhang, Y. und Xiong, Y., Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53., Mol. Cell., 1999, (3), 579-591.

Zhou, D.C., Simonin, G., Faussat, A.M., Zittoun, R., Marie, J.P., Effect of the multidrug inhibitor GG918 on drug sensitivity of human leukemic cells., Leukemia., 1997, (11), 1516-1522.

Zou, Z., Anisowicz, A., Hendrix, M.J., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., Sager, R., Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells., Science., 1994, (263), 526-529.

Zou, Z., Gao, C., Nagaich, A.K., Connell, T., Saito, S., Moul, J.W., Seth, P., Appella, E., Srivastava, S., p53 regulates the expression of the tumor suppressor gene maspin., J Biol. Chem., 2000, (275), 6051-6054.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
12.10.2006